Neonatal screening for cystic fibrosis: France rises to the challenge
- 1 December 2003
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 26 (8) , 729-744
- https://doi.org/10.1023/b:boli.0000009921.42503.c2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- [Molecular genetics: pre- and post-analytic "best practices"].2002
- Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian populationJournal of Medical Screening, 2002
- [Genetic testing for cystic fibrosis: evaluation of the Elucigene CF20 kit in blood and buccal cells].2001
- Neonatal screening for cystic fibrosis: result of a pilot study using both immunoreactive trypsinogen and cystic fibrosis gene mutation analysesHuman Genetics, 1995
- Neonatal screening in FranceScreening, 1993
- Results of pilot screening activities in the French neonatal screening program — cystic fibrosis, congenital adrenal hyperplasia and sickle cell diseaseScreening, 1993
- Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.BMJ, 1991
- Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosisClinical Genetics, 1990
- Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)Nucleic Acids Research, 1989
- REDUCED MORBIDITY IN PATIENTS WITH CYSTIC FIBROSIS DETECTED BY NEONATAL SCREENINGThe Lancet, 1985